|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01830 PERFECT MEDICAL
Nominal 
2.220 0.000 (0.000%) | 2024/09 - Interim HKD(K$) | %Chg (Compare to Interim) | 2023/09 HKD(K$) | 2022/09 HKD(K$) | 2021/09 HKD(K$) | 2020/09 HKD(K$) | |
| Turnover | 620,272 | -13.629% | 718,149 | 668,300 | 801,644 | 509,807 |
| Cost of Sales | -- | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- | -- |
| 2024/09 - Interim HKD(K$) | %Chg (Compare to Interim) | 2023/09 HKD(K$) | 2022/09 HKD(K$) | 2021/09 HKD(K$) | 2020/09 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 159,920 | -21.518% | 203,767 | 180,924 | 267,746 | 170,089 | |
| Taxation | (28,576) | -23.540% | (37,374) | (30,266) | (51,332) | (34,454) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 9,500 | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 140,844 | -15.355% | 166,393 | 150,658 | 216,414 | 135,635 | |
| 2024/09 - Interim HKD(K$) | %Chg (Compare to Interim) | 2023/09 HKD(K$) | 2022/09 HKD(K$) | 2021/09 HKD(K$) | 2020/09 HKD(K$) | |
| Net Finance Costs / (Income) | (1,442) | -21.374% | (1,834) | 6,122 | 7,069 | 1,603 |
| Depreciation & Amortisation | 91,542 | -10.846% | 102,679 | 114,115 | 102,381 | 81,711 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2024/09 - Interim | %Chg (Compare to Interim) | 2023/09 | 2022/09 | 2021/09 | 2020/09 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2024/09 - Interim | %Chg (Compare to Interim) | 2023/09 | 2022/09 | 2021/09 | 2020/09 | |
| EPS (cts) | 11.200 | -15.152% | 13.200 | 12.100 | 17.700 | 12.100 |
| DPS (cts) | 11.300 | -- | 14.200 | 13.000 | 17.700 | 13.000 |
| Dividend Payout Ratio (%) | 100.893% | -- | 107.576% | 107.438% | 100.000% | 107.438% |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 0.360 | -- | 0.430 | 0.480 | 0.696 | 0.748 |
| Remarks: | Real time quote last updated: 20/12/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders ($) | HKD 140,844,000 |
| %Change | -15.355% |
| EPS / (LPS) | HKD 0.112 |
| NBV Per Share ($) | HKD 0.360 |